MedTrace Logo

Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects

NCT01882296 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-06-20

No results posted yet for this study

Summary

Primary object: Evaluate Pharmacodynamic property and safety administered S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in healthy male subjects

Secondary object : Evaluate Dose-response of S-pantoprazole and pantoprazole and compare each dose-response

Conditions

  • Healthy Male Subjects

Interventions

DRUG

AGSPT_10

AGSPT 10mg for 7days administration

DRUG

AGSPT_20

AGSPT 20mg for 7days administration

DRUG

AGSPT_40

AGSPT 20mg x 2tablet for 7days administration

DRUG

Pantoprazole_20

Pantoprazole 20mg for 7days administration

DRUG

Pantoprazole_40

Pantoprazole 40mg for 7days administration

Sponsors & Collaborators

  • Ahn-Gook Pharmaceuticals Co.,Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Primary Completion
2013-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01882296 on ClinicalTrials.gov